VAERS reports by lot

GSK DTaP/Tdap lot PT2RK: VAERS reports

38 VAERS reports list lot PT2RK as a GSK DTaP/Tdap vaccine, received between 2017-04-26 and 2023-07-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
13%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4559%
Allergic / Anaphylactic1114%
General / Systemic (non-local)912%
Dermatological (non-injection-site)79%
Cardiac / Cardiovascular23%
Musculoskeletal11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas5
Michigan5
California4
Missouri4
Oregon3
Alabama2
Florida2
New Hampshire2
North Carolina1
Ohio1
Colorado1
Montana1

Reports by month received

2017-041
2017-061
2017-072
2017-094
2017-102
2017-112
2017-124
2018-014
2018-031
2018-043
2018-052
2018-061
2018-071
2018-085
2018-111
2019-051
2019-072
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.